Loading clinical trials...
Loading clinical trials...
Effects of Paracervical Block With Combined Ketorolac and Lidocaine on Perceived Pain in Osmotic Dilator Placement for Abortion, a Randomized Controlled Trial
Conditions
Interventions
Ketorolac
oral ibuprofen
+3 more
Locations
1
United States
Rush University Medical Center
Chicago, Illinois, United States
Start Date
May 1, 2026
Primary Completion Date
April 30, 2027
Completion Date
April 30, 2027
Last Updated
March 23, 2026
NCT07368413
NCT07534982
NCT07208799
NCT07410000
NCT07423650
NCT06995534
Lead Sponsor
Rush University Medical Center
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions